Julian Smith

Phone

Professional Bio

Professor Julian Smith is the Professor of Surgery at Monash University and the Senior Cardiothoracic Surgeon at the Victorian Heart Hospital (Monash Health). He has been involved with the ANZSCTS Database in multiple capacities for over 20 years.

Julian's Presentations

View Program

Database Report

5:10 pm 08 November 2024

Ballroom 1

Julian Smith

Results of the CLIP-II Cryopreserved vs. Liquid Platelets phase III randomised controlled trial (NCT03991481)

4:05 pm 09 November 2024

Laguna 2

Julian Smith

A PHASE 3 STUDY OF ravulizumab TO PROTECT PATIENTS WITH CHRONIC KIDNEY DISEASE FROM CARDIAC SURGERY ASSOCIATED ACUTE KIDNEY INJURY AND MAJOR ADVERSE KIDNEY EVENTS: THE ARTEMIS STUDY

Julian Smith

Results of the CLIP-II Cryopreserved vs. Liquid Platelets phase III randomised controlled trial (NCT03991481)

4:05 pm 09 November 2024

Laguna 2

Julian Smith

A PHASE 3 STUDY OF ravulizumab TO PROTECT PATIENTS WITH CHRONIC KIDNEY DISEASE FROM CARDIAC SURGERY ASSOCIATED ACUTE KIDNEY INJURY AND MAJOR ADVERSE KIDNEY EVENTS: THE ARTEMIS STUDY

Julian Smith

Results of the CLIP-II Cryopreserved vs. Liquid Platelets phase III randomised controlled trial (NCT03991481)

4:05 pm 09 November 2024

Laguna 2

Julian Smith

A PHASE 3 STUDY OF ravulizumab TO PROTECT PATIENTS WITH CHRONIC KIDNEY DISEASE FROM CARDIAC SURGERY ASSOCIATED ACUTE KIDNEY INJURY AND MAJOR ADVERSE KIDNEY EVENTS: THE ARTEMIS STUDY

Julian Smith

Database Report

5:10 pm 08 November 2024

Ballroom 1

Julian Smith

Results of the CLIP-II Cryopreserved vs. Liquid Platelets phase III randomised controlled trial (NCT03991481)

4:05 pm 09 November 2024

Laguna 2

Julian Smith

A PHASE 3 STUDY OF ravulizumab TO PROTECT PATIENTS WITH CHRONIC KIDNEY DISEASE FROM CARDIAC SURGERY ASSOCIATED ACUTE KIDNEY INJURY AND MAJOR ADVERSE KIDNEY EVENTS: THE ARTEMIS STUDY

Julian Smith

A PHASE 3 STUDY OF ravulizumab TO PROTECT PATIENTS WITH CHRONIC KIDNEY DISEASE FROM CARDIAC SURGERY ASSOCIATED ACUTE KIDNEY INJURY AND MAJOR ADVERSE KIDNEY EVENTS: THE ARTEMIS STUDY

Julian Smith

Database Report

5:10 pm 08 November 2024

Ballroom 1

Julian Smith

Results of the CLIP-II Cryopreserved vs. Liquid Platelets phase III randomised controlled trial (NCT03991481)

4:05 pm 09 November 2024

Laguna 2

Julian Smith

A PHASE 3 STUDY OF ravulizumab TO PROTECT PATIENTS WITH CHRONIC KIDNEY DISEASE FROM CARDIAC SURGERY ASSOCIATED ACUTE KIDNEY INJURY AND MAJOR ADVERSE KIDNEY EVENTS: THE ARTEMIS STUDY

Julian Smith

Database Report

5:10 pm 08 November 2024

Ballroom 1

Julian Smith